Company / Shareholders' Equity
Zai Lab Ltd Shareholders' Equity History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$715.5M
FY2025
5-year range
$294.7M / $1.2B
FY2021-FY2025
Trend
-14.9%
vs FY2024
Sector context
#63 of 213
Health Care
What the data says
At $716M, Zai Lab Ltd's shareholders' equity ranks #63 of 213 in the Health Care sector. Shareholders' Equity has fluctuated over the past 8 years, ranging from $251M in FY2020 to $1.2B in FY2022.
Based on SEC 10-K filings.
$716M in FY2025 with a 5-year CAGR of +23.3%.
Declined from $796M to $716M over the past 2 years.
Health Care sector context is included.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -15.1%
- 5-Year CAGR
- +23.3%
- 10-Year CAGR
- -
Sector benchmark
#63 of 213 in Health CareTop 30% of 213This company $715.5M Sector average $2.5B
▼
-71.9% below sector average
Key checks
Key Insights
- 5-year CAGR of +23.3%, indicating consistent growth.
- In FY2025, shareholders' equity decreased 14.9% year-over-year.
- Ranks #63 out of 213 companies in the Health Care sector.
- Peak shareholders' equity was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score -1.09 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $715.5M | -14.9% |
| FY2024 | $840.9M | +5.6% |
| FY2023 | $796.1M | -31.9% |
| FY2022 | $1.2B | +296.8% |
| FY2021 | $294.7M | +17.4% |
| FY2020 | $251.1M | -14.8% |
| FY2019 | $294.7M | +17.4% |
| FY2018 | $251.1M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026